mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.5 |
mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
-0.034 |
0.5 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
marinopyrrole A |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.5 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.5 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |